IPCALAB.NS
IPCA Laboratories Ltd
Price:  
1,444.40 
INR
Volume:  
141,349.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IPCALAB.NS EV/EBITDA

10.9%
Upside

As of 2025-08-06, the EV/EBITDA ratio of IPCA Laboratories Ltd (IPCALAB.NS) is 20.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IPCALAB.NS's latest enterprise value is 375,495.70 mil INR. IPCALAB.NS's TTM EBITDA according to its financial statements is 18,189.40 mil INR. Dividing these 2 quantities gives us the above IPCALAB.NS EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 20.0x - 23.6x 21.8x
Forward P/E multiples 18.8x - 21.5x 20.2x
Fair Price 1,401.12 - 1,791.95 1,601.45
Upside -3.0% - 24.1% 10.9%
1,444.40 INR
Stock Price
1,601.45 INR
Fair Price

IPCALAB.NS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-10 20.64
2025-07-09 20.85
2025-07-08 20.97
2025-07-07 20.81
2025-07-04 20.40
2025-07-03 20.25
2025-07-02 19.72
2025-07-01 19.65
2025-06-30 19.85
2025-06-27 19.05
2025-06-26 19.24
2025-06-25 19.49
2025-06-24 19.07
2025-06-23 19.12
2025-06-20 19.88
2025-06-19 19.54
2025-06-18 19.46
2025-06-17 19.43
2025-06-16 19.54
2025-06-13 19.58
2025-06-12 19.79
2025-06-11 19.88
2025-06-10 19.62
2025-06-09 19.59
2025-06-06 19.62
2025-06-05 19.75
2025-06-04 19.94
2025-06-03 20.03
2025-06-02 20.10
2025-05-30 20.41
2025-05-29 21.11
2025-05-28 21.30
2025-05-27 20.76
2025-05-26 20.93
2025-05-23 20.88
2025-05-22 20.60
2025-05-21 21.14
2025-05-20 20.64
2025-05-19 20.53
2025-05-16 19.90
2025-05-15 20.14
2025-05-14 20.33
2025-05-13 20.15
2025-05-12 19.48
2025-05-09 19.41
2025-05-08 19.35
2025-05-07 19.48
2025-05-06 19.62
2025-05-05 19.75